Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Acarbose
Drug ID BADD_D00018
Description Acarbose is a complex oligosaccharide that acts as an inhibitor of several enzymes responsible for the breakdown of complex carbohydrates in the intestines. It inhibits both pancreatic alpha-amylase and membrane-bound alpha-glucosidases - including intestinal glucoamylase, sucrase, maltase, and isomaltase - which are responsible for the metabolism of complex starches and oligo-, tri-, and disaccharides into absorbable simple sugars.[L31633,A37868] By inhibiting the activity of these enzymes, acarbose limits the absorption of dietary carbohydrates and the subsequent postprandial increase in blood glucose and insulin levels. Acarbose is therefore used in conjunction with diet, exercise, and other pharmacotherapies for the management of blood sugar levels in patients with type 2 diabetes.[L31628,L31633] Acarbose is one of only two approved alpha-glucosidase inhibitors (the other being [miglitol]), receiving its first FDA approval in 1995 under the brand name Precose (since discontinued).[L31668] This class of antidiabetic therapy is not widely used due to their relatively modest impact on A1c, their requirement for thrice-daily dosing, and the potential for significant gastrointestinal adverse effects.[L31668]
Indications and Usage Acarbose is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.[L31628]
Marketing Status approved; investigational
ATC Code A10BF01
DrugBank ID DB00284
KEGG ID D00216
MeSH ID D020909
PubChem ID 444254
TTD Drug ID D0AD5C
NDC Product Code 72789-133; 65897-1005; 42291-131; 62135-453; 0054-0142; 71335-1583; 72789-131; 52972-0035; 23155-149; 42291-130; 63629-5698; 69543-122; 71335-9725; 64380-758; 71205-854; 62135-454; 64380-759; 64380-760; 72789-132; 50090-4952; 69543-120; 69543-121; 42513-0016; 42291-132; 62135-455; 0054-0140; 58623-0022; 65897-4005; 71052-656; 23155-148; 71205-856; 23155-147; 0054-0141; 71205-855; 43353-951
UNII T58MSI464G
Synonyms Acarbose | Glumida | Glucobay | Glucor | Bay g 5421 | Prandase | Precose
Chemical Information
Molecular Formula C25H43NO18
CAS Registry Number 56180-94-0
SMILES CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Intestinal perforation07.04.06.002--Not Available
Intussusception07.13.01.008--Not Available
Jaundice23.03.03.030; 09.01.01.004; 01.06.04.004--Not Available
Ketoacidosis14.01.01.0080.001084%Not Available
Liver disorder09.01.08.001--Not Available
Liver function test abnormal13.03.04.030--Not Available
Malaise08.01.01.0030.001084%
Nausea07.01.07.001--
Oedema14.05.06.010; 08.01.07.006--Not Available
Palpitations02.11.04.0120.001084%
Pruritus23.03.12.0010.004334%
Pyrexia08.05.02.0030.002167%
Rash23.03.13.001--Not Available
Rectal haemorrhage24.07.02.018; 07.12.03.001--
Thrombocytopenia01.08.01.002--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Volvulus07.13.01.012--Not Available
Vomiting07.01.07.0030.002167%
Pneumoperitoneum07.07.01.0080.002167%Not Available
Subileus07.13.01.004--Not Available
Pneumatosis08.01.03.044--Not Available
Lymphatic disorder01.09.01.003--Not Available
Foetor hepaticus09.01.05.006; 07.01.06.026--Not Available
Colitis microscopic07.08.01.0110.002167%Not Available
Pneumatosis intestinalis07.11.01.0430.003792%Not Available
Intestinal haemorrhage24.07.02.031; 07.12.03.005--Not Available
Angiopathy24.03.02.007--Not Available
Blood disorder01.05.01.004--Not Available
Drug intolerance08.06.01.0130.003684%Not Available
Hepatobiliary disease09.01.08.003--Not Available
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages